Cleared Traditional

K781086 - INSULIN AUTOPAK

K781086 is an FDA 510(k) clearance for INSULIN AUTOPAK, manufactured by Micromedic Systems. The device is a Class 1 Toxicology device with product code CFP cleared through the Traditional 510(k) pathway after a 46-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1978
Decision
46d
Days
Class 1
Risk

K781086 is an FDA 510(k) clearance for the INSULIN AUTOPAK. Classified as Radioimmunoassay, Immunoreactive Insulin (product code CFP), Class I - General Controls.

Submitted by Micromedic Systems (Mchenry, US). The FDA issued a Cleared decision on August 14, 1978 after a review of 46 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.1405 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K781086

510(k) Number K781086 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 1978
Decision Date August 14, 1978
Days to Decision 46 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 87d · This submission: 46d
Pathway characteristics
Predicate-based equivalence.

CFP Device Classification - Class 1, General Controls

Product Code CFP Radioimmunoassay, Immunoreactive Insulin
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1405
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CFP Radioimmunoassay, Immunoreactive Insulin

All 26
Devices cleared under the same product code (CFP) and FDA review panel - the closest regulatory comparables to K781086.
AUTOPAK 12 INSULIN TEST DELIVERY SYSTEM
K792279 · Micromedic Systems · Dec 1979
CENTRIA INSULIN RIA
K791707 · Ventrex Laboratories, Inc. · Oct 1979
RIA, INSULIN, DOUBLE ANTIBODY
K790630 · Endocrine-Metabolic Center · Jul 1979
INSULIN RIA KIT
K781285 · Serono Laboratories, Inc. · Aug 1978
INSULIN RIA MODULE
K771947 · Inter Science Institute · Jan 1978
RSL INSULIN KIT
K772281 · Radioassay Systems Laboratories, Inc. · Jan 1978